AMIANNE HUFFMAN: Open Payments
NPI 1144779059 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 45 payments from 16 companies in 2025. Trend: 2023 $877 · 2024 $474 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $176 |
| Novo Nordisk Inc | 11 | $170 |
| Lilly USA, LLC | 6 | $126 |
| ABBVIE INC. | 3 | $66 |
| Boston Scientific Corporation | 1 | $56 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Astellas Pharma US Inc | 2 | $43 |
| Seqirus USA Inc | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| ALK-Abello, Inc | 1 | $27 |
Products named: NURTEC ODT, MOUNJARO, Wegovy, WaveWriter Alpha Prime 16, Rybelsus, Veozah, PREVNAR 20, BEXSERO.
Industry payments across CA — which companies pay providers there.
